Correlation Between Catalyst Pharmaceuticals and Iridium Communications
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and Iridium Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and Iridium Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and Iridium Communications, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and Iridium Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of Iridium Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and Iridium Communications.
Diversification Opportunities for Catalyst Pharmaceuticals and Iridium Communications
0.3 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Catalyst and Iridium is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and Iridium Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Iridium Communications and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with Iridium Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Iridium Communications has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and Iridium Communications go up and down completely randomly.
Pair Corralation between Catalyst Pharmaceuticals and Iridium Communications
Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 0.67 times more return on investment than Iridium Communications. However, Catalyst Pharmaceuticals is 1.5 times less risky than Iridium Communications. It trades about 0.1 of its potential returns per unit of risk. Iridium Communications is currently generating about 0.06 per unit of risk. If you would invest 1,974 in Catalyst Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of 233.00 from holding Catalyst Pharmaceuticals or generate 11.8% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Catalyst Pharmaceuticals vs. Iridium Communications
Performance |
| Timeline |
| Catalyst Pharmaceuticals |
| Iridium Communications |
Catalyst Pharmaceuticals and Iridium Communications Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Catalyst Pharmaceuticals and Iridium Communications
The main advantage of trading using opposite Catalyst Pharmaceuticals and Iridium Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, Iridium Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Iridium Communications will offset losses from the drop in Iridium Communications' long position.| Catalyst Pharmaceuticals vs. Day One Biopharmaceuticals | Catalyst Pharmaceuticals vs. Terns Pharmaceuticals | Catalyst Pharmaceuticals vs. X4 Pharmaceuticals | Catalyst Pharmaceuticals vs. Inozyme Pharma |
| Iridium Communications vs. IHS Holding | Iridium Communications vs. Cogent Communications Group | Iridium Communications vs. IDT Corporation | Iridium Communications vs. Cable One |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |